How Much? A Battle Over The Cost Of The New Hepatitis C Drugs
As excitement mounts among physicians and investors over a new crop of drugs for treating hepatitis C, there is also concern that patients in developing countries may not have sufficient access due to high prices. But a recent poster presentation at a medical conference suggests that drugmakers can produce these new medicines for relatively little […]
How Much? A Battle Over The Cost Of The New Hepatitis C Drugs Read More »